Multifaceted Bioavailability: Strategies, Delivery, Food Interactions

Isabella Conti^*
*Correspondence: Isabella Conti, Department of Medicinal Chemistry, Rome Institute of Life Sciences, Italy, Email:

Introduction

Bioavailability, the fraction of an administered dose of unchanged drug that reaches the systemic circulation, is a critical parameter influencing therapeutic efficacy and patient outcomes. Many pharmacologically active compounds, including synthetic drugs, natural products, and even probiotics, face significant challenges in achieving optimal bioavailability due to factors such as poor water solubility, low permeability, extensive metabolism, or degradation within the biological environment. Addressing these limitations is paramount for advancing drug development and nutritional science. A primary hurdle in drug development involves improving the oral bioavailability of poorly water-soluble drugs. Strategies to tackle this common challenge include particle size reduction, solid dispersions, and lipid-based formulations, all designed to enhance dissolution and absorption. Understanding the mechanisms and applications of these approaches is key to achieving better absorption and therapeutic outcomes [1].

Lipid-based formulations, in particular, are at the forefront of revolutionizing the delivery of drugs that struggle with water solubility. These systems operate by improving dissolution and absorption, offering practical solutions to significant pharmaceutical hurdles [4].

Natural compounds, often celebrated for their therapeutic potential, frequently suffer from poor absorption, limiting their effectiveness. Innovative approaches, such as nanocarrier systems and strategic structural modifications, are being explored to overcome these inherent limitations. The goal is to fully unlock the therapeutic promise of these complex molecules, paving the way for more effective and predictable natural product formulations [2].

Similarly, herbal medicines present unique challenges, with poor solubility and extensive metabolism often hindering their oral bioavailability. Comprehensive reviews highlight a range of techniques, from chemical modification to advanced delivery systems, aimed at boosting the therapeutic efficacy of these traditional remedies [9].

Beyond oral administration, enhancing bioavailability for other routes is also a focus. Transdermal drug delivery systems are seeing innovations designed to boost the bioavailability of drugs applied to the skin. Approaches like nanocarriers and microneedles are demonstrating how targeted delivery can circumvent skin barrier limitations, improving both local and systemic therapeutic effects [5].

Nanotechnology emerges as a powerful tool across multiple fronts in addressing poor bioavailability. For oral drug delivery, various nano-formulations, including nanoparticles and nanomicelles, are harnessed to improve drug dissolution, stability, and absorption across biological barriers for poorly soluble drugs [6].

This advanced field also contributes to the broader challenge of poor drug permeability across biological membranes, which can significantly limit oral bioavailability. Novel strategies and excipients are being developed to enhance drug absorption by modulating membrane transport, ultimately leading to better therapeutic outcomes for difficult-to-deliver compounds [10].

The role of the food matrix and dietary interactions also profoundly impacts bioavailability. A systematic review underscores how the processing, preparation, and consumption of food can significantly alter the absorption of essential nutrients and beneficial phytochemicals, illustrating the complexity beyond just the raw content [3].

Furthermore, drug-food interactions can either enhance or diminish the absorption and efficacy of medications. Recognizing these interactions is crucial for optimizing patient dosing and minimizing adverse effects, ensuring that medications are as effective as intended [8].

Even the delivery of living organisms, such as probiotics, presents bioavailability challenges concerning their viability and efficacy. Current strategies focus on protecting probiotics through the harsh digestive environment to ensure more live bacteria reach the gut where they can exert their beneficial effects [7].

Collectively, these diverse research efforts highlight a concerted global initiative to improve the delivery and absorption of a wide array of active substances, ultimately leading to enhanced health outcomes and more effective treatments.

Description

The overarching goal across pharmaceutical and nutritional sciences is to optimize the bioavailability of active compounds, ensuring they reach their target sites effectively and exert their desired therapeutic or health benefits. This involves tackling various inherent challenges that limit absorption and distribution within the body. A significant body of research focuses on enhancing the oral bioavailability of poorly water-soluble drugs, a persistent problem in drug development [1]. Researchers explore methods like particle size reduction, which increases surface area for dissolution, and solid dispersions, which aim to create amorphous or molecularly dispersed drug states. Additionally, lipid-based formulations are increasingly vital, as they facilitate drug solubilization and absorption through mechanisms that bypass some limitations of aqueous environments [4]. These strategies collectively seek to improve dissolution and absorption, directly translating to better therapeutic outcomes [1, 4].

The scope of bioavailability enhancement extends beyond synthetic pharmaceuticals to natural compounds and traditional remedies. Many natural products and active components from herbal medicines often suffer from poor absorption and extensive first-pass metabolism, which severely limits their therapeutic potential [2, 9]. To overcome these issues, innovative approaches include the development of nanocarrier systems, which can encapsulate and protect sensitive compounds while improving their solubility and permeability [2]. Structural modifications of the compounds themselves, as well as advanced delivery systems, are also employed to enhance the oral bioavailability of herbal medicines, aiming to boost the efficacy of traditional treatments [9]. The goal is to make these valuable natural agents more effective and predictable in their action [2].

Nanotechnology plays a transformative role across various drug delivery platforms. For oral administration, nanotechnology-based approaches like nanoparticles and nanomicelles are critically reviewed for their ability to improve drug dissolution, enhance stability, and facilitate absorption across biological barriers, particularly for poorly soluble drugs [6]. Furthermore, these advancements are crucial for addressing poor drug permeability across biological membranes, a factor that significantly restricts oral bioavailability. Novel strategies incorporating excipients and advanced formulations are being developed to modulate membrane transport, thereby improving the absorption of difficult-to-deliver compounds and leading to superior therapeutic results [10]. This technological push isn't limited to oral routes, extending to transdermal delivery systems. Innovations like nanocarriers and microneedles are designed to overcome the skin's barrier properties, enabling targeted delivery and improving both local and systemic therapeutic effects for drugs applied to the skin [5].

Beyond formulation and delivery technology, the interaction of substances with their biological environment and dietary components is a critical consideration. The food matrix, for instance, has a profound influence on the bioavailability of essential nutrients and beneficial phytochemicals. Systematic reviews highlight that the way food is processed, prepared, and consumed can significantly alter how much of these vital compounds our bodies actually absorb, emphasizing the complexity that goes beyond just the inherent content of the food [3]. Similarly, drug-food interactions are a major area of study, as certain foods can either enhance or diminish the absorption and efficacy of medications. A clear understanding of these interactions is indispensable for optimizing patient dosing regimens and minimizing the risk of adverse drug effects, ensuring patient safety and treatment effectiveness [8].

Finally, challenges extend to the delivery of live biological agents, such as probiotics. Ensuring the viability and efficacy of probiotics requires specialized delivery systems that can protect them through the harsh acidic environment of the digestive tract. Current developments focus on innovative encapsulation and formulation techniques to guarantee that a sufficient number of live bacteria reach the gut, where they can exert their intended beneficial effects, thereby improving their overall bioavailability and impact on gut health [7]. This comprehensive array of research underscores a continuous drive to enhance the bioavailability of a wide spectrum of substances, from pharmaceuticals to nutraceuticals, through advanced science and technology.

Conclusion

The provided research highlights a multifaceted approach to improving the bioavailability of various compounds, which is crucial for maximizing therapeutic outcomes and nutritional benefits. A significant challenge lies with poorly water-soluble drugs, for which strategies such as particle size reduction, solid dispersions, and lipid-based formulations are explored to enhance dissolution and absorption. Nanotechnology, employing systems like nanoparticles and nanomicelles, presents a robust solution for both oral and dermal delivery, addressing issues of drug stability and permeability across biological barriers. The scope extends beyond synthetic drugs to natural products and herbal medicines, where advanced delivery systems and structural modifications are vital for unlocking their full therapeutic potential, often hampered by poor absorption and extensive metabolism. Even probiotics, essential for gut health, require specialized delivery systems to ensure their viability through harsh digestive environments, guaranteeing live bacteria reach their target. The interaction between substances and the food matrix is another critical aspect. Studies reveal that food processing, preparation, and consumption patterns can significantly alter the absorption of nutrients and beneficial phytochemicals. Similarly, drug-food interactions are shown to profoundly impact medication efficacy by affecting absorption. Understanding these complex interplay allows for optimized dosing and minimizes adverse effects, reinforcing that bioavailability is not solely about the substance itself but also its environment and delivery mechanism.

Acknowledgement

None

Conflict of Interest

None

References

1. Md SU, Md SIK, Md KI. "Strategies for enhancing oral bioavailability of poorly water-soluble drugs: a comprehensive review".J Pharm Anal 13 (2023):597-613.

Indexed at, Google Scholar, Crossref

2. Yu-Chi H, Tzu-Jung T, Ying-Tzu C. "Enhancing the Bioavailability of Natural Products: Recent Advances and Future Perspectives".Pharmaceutics 14 (2022):2182.

Indexed at, Google Scholar, Crossref

3. Anna GL, Bas vdP, Erik JK. "Influence of food matrix on the bioavailability of nutrients and phytochemicals: a systematic review".Food Funct 12 (2021):4423-4444.

Indexed at, Google Scholar, Crossref

4. Jin-Hee L, Hyunjin K, Yu-Ri K. "Recent advances in lipid-based formulations for enhancing the oral bioavailability of poorly water-soluble drugs".Arch Pharm Res 46 (2023):295-312.

Indexed at, Google Scholar, Crossref

5. Subheet KJ, Manish K, Abhishek S. "Enhancing dermal bioavailability of drugs: A review of recent advancements in novel drug delivery systems".J Drug Deliv Sci Technol 56 (2020):101569.

Indexed at, Google Scholar, Crossref

6. Md. SA, Md. AI, Md. SA. "Nanotechnology-based approaches for enhancing oral bioavailability of poorly soluble drugs: a critical review".J Drug Deliv Sci Technol 74 (2022):103607.

Indexed at, Google Scholar, Crossref

7. Qiufen D, Yaqi F, Xiaoxi L. "Probiotic delivery systems: current developments and challenges for improved bioavailability".J Future Foods 3 (2023):1-13.

Indexed at, Google Scholar, Crossref

8. Jinhwan K, Joongwon S, Sang MO. "Drug-food interactions and their impact on drug bioavailability: a review".Arch Pharm Res 44 (2021):11-25.

Indexed at, Google Scholar, Crossref

9. Hongyan Z, Peng L, Xinxin W. "Enhancing the oral bioavailability of herbal medicines: a comprehensive review of strategies and approaches".J Ethnopharmacol 247 (2020):112278.

Indexed at, Google Scholar, Crossref

10. Jing Z, Jing-Jing Y, Dan-Dan Z. "Recent advances in strategies for improving oral absorption and bioavailability of drugs with poor permeability".J Pharm Anal 13 (2023):651-667.

Indexed at, Google Scholar, Crossref